Albireo Pharma, Inc. - stock earnings
Stock symbol ALBO is outdated, potentially delisted? Maybe it is available on other exchange?
ALBO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q3 | -37.8 million USD | 9.8 million USD |
| 2022Q2 | -39.9 million USD | 8.2 million USD |
| 2022Q1 | -42.4 million USD | 6.8 million USD |
| 2021Q4 | -11.0 million USD | 32.5 million USD |
| 2021Q3 | 57.1 million USD | 3.7 million USD |
| 2021Q2 | -36.4 million USD | 2.4 million USD |
| 2021Q1 | -43.7 million USD | 2.0 million USD |
| 2020Q4 | -24.8 million USD | 2.7 million USD |
| 2020Q3 | -30.7 million USD | 2.1 million USD |
ALBO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -34.0 million USD | 40.6 million USD |
| 2020 | -107.6 million USD | 8.3 million USD |
| 2019 | -62.7 million USD | 9.6 million USD |
| 2018 | -46.1 million USD | 12.7 million USD |
| 2017 | -24.4 million USD | 1000 USD |
ALBO
Price: $44.15
52 week price:
Earnings Per Share: -6.56 USD
P/E Ratio: -11.67
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 110602
Ebitda: -6.5 millionMarket Capitalization: 920.7 million